In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...
The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company. Asuka Koda covers the Yale ...
Boston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, ...
Accra [Ghana]/ Mumbai (Maharashtra) [India], November 14: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks 'World Diabetes Day 2024' together with Africa's First Ladies, Ministries ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, ...
2d
Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...
Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...
First Lady Monica Chakwera and other African First Ladies have commended Merck Foundation for various activities it is ...
Rahway: Merck, known as MSD outside of the United States and Canada, and Moderna, Inc., announced the initiation of INTerpath ...
data-text="Merck Announces Emerging Biotech Grant Program Winners" data-link=" Announces Emerging Biotech Grant Program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback